[CNP_P13] Poster Session 13

[CNP-P13-2] Safety and Tolerability of Atypical Antipsychotics in the Treatment of Bipolar Depression: A Systematic Review and Meta-Analysis of Placebo-Controlled Monotherapy and Adjunctive Therapy Trials

^○Tadashi NOSAKA¹, Katsuhiko HAGI¹, Andrei PIKALOV² (1. Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceuticals, Inc, Marlborough, MA and Fort Lee, NJ, USA)